Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease

Graham R. Ogden (Lead / Corresponding author), Derrick M. Chisholm, Arthur M. Morris, J. Howard Stevenson

    Research output: Contribution to journalArticle

    34 Citations (Scopus)

    Abstract

    Recent reports of p53 positivity in the normal mucosa of some head and neck cancer patients have been taken as evidence for field cancerization and hence a likelihood of the development of further tumours, yet few papers report the clinical significance of this finding through long-term follow- up. The immunohistochemical detection of p53 expression in clinically and histopathologically normal oral mucosa taken from the wound margin following excision of oral cancer was assessed using the polyclonal antibody CM1. Fresh frozen biopsies of normal oral mucosa and the corresponding tumour from 21 oral cancer patients and of normal mucosa from 25 non-cancer patients were assessed for p53 overexpression. The 'normal' mucosa was positive in 12 of the oral cancer patients and one of the non-cancer patients. Second malignant turnouts were seen in patients from whom p53-positive 'normals' and p53- negative 'normals' were recorded. In five of the p53-positive 'normals', the corresponding cancer was p53-negative. In one case, where 'normal' mucosa was available from more than one site, one region was positive, whilst the other was negative. No obvious difference in age, tobacco use, or recurrence rate was seen between positive and negative cases. All patients who were still alive were reviewed for a minimum of 5 years. Using Fisher's exact test, no statistically significant difference was found for the rate of second malignant turnouts occurring in patients with p53-positive compared with p53- negative normal mucosa. Thus, the detection of p53 in normal mucosa did not necessarily predict a further tumour.
    Original languageEnglish
    Pages (from-to)180-184
    Number of pages5
    JournalJournal of Pathology
    Volume182
    Issue number2
    DOIs
    Publication statusPublished - Jun 1997

    Fingerprint

    Mouth Neoplasms
    Mouth Mucosa
    Mucous Membrane
    Neoplasms
    Tobacco Use
    Head and Neck Neoplasms
    Biopsy
    Recurrence
    Antibodies
    Wounds and Injuries

    Cite this

    Ogden, Graham R. ; Chisholm, Derrick M. ; Morris, Arthur M. ; Stevenson, J. Howard. / Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. In: Journal of Pathology. 1997 ; Vol. 182, No. 2. pp. 180-184.
    @article{d4f4cd43ace7425192f02712175cfab3,
    title = "Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease",
    abstract = "Recent reports of p53 positivity in the normal mucosa of some head and neck cancer patients have been taken as evidence for field cancerization and hence a likelihood of the development of further tumours, yet few papers report the clinical significance of this finding through long-term follow- up. The immunohistochemical detection of p53 expression in clinically and histopathologically normal oral mucosa taken from the wound margin following excision of oral cancer was assessed using the polyclonal antibody CM1. Fresh frozen biopsies of normal oral mucosa and the corresponding tumour from 21 oral cancer patients and of normal mucosa from 25 non-cancer patients were assessed for p53 overexpression. The 'normal' mucosa was positive in 12 of the oral cancer patients and one of the non-cancer patients. Second malignant turnouts were seen in patients from whom p53-positive 'normals' and p53- negative 'normals' were recorded. In five of the p53-positive 'normals', the corresponding cancer was p53-negative. In one case, where 'normal' mucosa was available from more than one site, one region was positive, whilst the other was negative. No obvious difference in age, tobacco use, or recurrence rate was seen between positive and negative cases. All patients who were still alive were reviewed for a minimum of 5 years. Using Fisher's exact test, no statistically significant difference was found for the rate of second malignant turnouts occurring in patients with p53-positive compared with p53- negative normal mucosa. Thus, the detection of p53 in normal mucosa did not necessarily predict a further tumour.",
    author = "Ogden, {Graham R.} and Chisholm, {Derrick M.} and Morris, {Arthur M.} and Stevenson, {J. Howard}",
    year = "1997",
    month = "6",
    doi = "10.1002/(SICI)1096-9896(199706)182:2<180::AID-PATH847>3.0.CO;2-L",
    language = "English",
    volume = "182",
    pages = "180--184",
    journal = "Journal of Pathology",
    issn = "0022-3417",
    publisher = "Wiley",
    number = "2",

    }

    Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease. / Ogden, Graham R. (Lead / Corresponding author); Chisholm, Derrick M.; Morris, Arthur M.; Stevenson, J. Howard.

    In: Journal of Pathology, Vol. 182, No. 2, 06.1997, p. 180-184.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Overexpression of p53 in normal oral mucosa of oral cancer patients does not necessarily predict further malignant disease

    AU - Ogden, Graham R.

    AU - Chisholm, Derrick M.

    AU - Morris, Arthur M.

    AU - Stevenson, J. Howard

    PY - 1997/6

    Y1 - 1997/6

    N2 - Recent reports of p53 positivity in the normal mucosa of some head and neck cancer patients have been taken as evidence for field cancerization and hence a likelihood of the development of further tumours, yet few papers report the clinical significance of this finding through long-term follow- up. The immunohistochemical detection of p53 expression in clinically and histopathologically normal oral mucosa taken from the wound margin following excision of oral cancer was assessed using the polyclonal antibody CM1. Fresh frozen biopsies of normal oral mucosa and the corresponding tumour from 21 oral cancer patients and of normal mucosa from 25 non-cancer patients were assessed for p53 overexpression. The 'normal' mucosa was positive in 12 of the oral cancer patients and one of the non-cancer patients. Second malignant turnouts were seen in patients from whom p53-positive 'normals' and p53- negative 'normals' were recorded. In five of the p53-positive 'normals', the corresponding cancer was p53-negative. In one case, where 'normal' mucosa was available from more than one site, one region was positive, whilst the other was negative. No obvious difference in age, tobacco use, or recurrence rate was seen between positive and negative cases. All patients who were still alive were reviewed for a minimum of 5 years. Using Fisher's exact test, no statistically significant difference was found for the rate of second malignant turnouts occurring in patients with p53-positive compared with p53- negative normal mucosa. Thus, the detection of p53 in normal mucosa did not necessarily predict a further tumour.

    AB - Recent reports of p53 positivity in the normal mucosa of some head and neck cancer patients have been taken as evidence for field cancerization and hence a likelihood of the development of further tumours, yet few papers report the clinical significance of this finding through long-term follow- up. The immunohistochemical detection of p53 expression in clinically and histopathologically normal oral mucosa taken from the wound margin following excision of oral cancer was assessed using the polyclonal antibody CM1. Fresh frozen biopsies of normal oral mucosa and the corresponding tumour from 21 oral cancer patients and of normal mucosa from 25 non-cancer patients were assessed for p53 overexpression. The 'normal' mucosa was positive in 12 of the oral cancer patients and one of the non-cancer patients. Second malignant turnouts were seen in patients from whom p53-positive 'normals' and p53- negative 'normals' were recorded. In five of the p53-positive 'normals', the corresponding cancer was p53-negative. In one case, where 'normal' mucosa was available from more than one site, one region was positive, whilst the other was negative. No obvious difference in age, tobacco use, or recurrence rate was seen between positive and negative cases. All patients who were still alive were reviewed for a minimum of 5 years. Using Fisher's exact test, no statistically significant difference was found for the rate of second malignant turnouts occurring in patients with p53-positive compared with p53- negative normal mucosa. Thus, the detection of p53 in normal mucosa did not necessarily predict a further tumour.

    UR - http://www.scopus.com/inward/record.url?scp=0030744653&partnerID=8YFLogxK

    U2 - 10.1002/(SICI)1096-9896(199706)182:2<180::AID-PATH847>3.0.CO;2-L

    DO - 10.1002/(SICI)1096-9896(199706)182:2<180::AID-PATH847>3.0.CO;2-L

    M3 - Article

    VL - 182

    SP - 180

    EP - 184

    JO - Journal of Pathology

    JF - Journal of Pathology

    SN - 0022-3417

    IS - 2

    ER -